H-CYTE, Inc. has named Michael Yurkowsky as its Chief Executive Officer effective immediately. Michael Yurkowsky brings more than 25 years of experience in financial services to H-CYTE. He currently has served on the Company?s board of directors since 2019. He also serves as President and Chairman of Deverra Therapeutics, a clinical stage biotech developing allogeneic cell therapies. Through his family office, YP Holdings, Mr. Yurkowsky has invested in over 50 public and private companies in the Life Sciences sector. Throughout his career, Mr. Yurkowsky has served on multiple public and private boards and has been involved in several M&A transactions.